Longeveron Inc. (LGVN)

NASDAQ: LGVN · Real-Time Price · USD

0.8600

+0.1795 (26.38%)

At close: Aug 13, 2025, 4:00 PM

0.8140

-0.0460 (-5.35%)

Pre-market: Aug 14, 2025, 9:16 AM EDT

Longeveron Employees

Longeveron had 25 employees as of December 31, 2024. The number of employees increased by 1 or 4.17% compared to the previous year.

Employees

25

Change (1Y)

1

Growth (1Y)

4.17%

Revenue / Employee

$82,920

Profits / Employee

-$1,087,640

Market Cap

17.74M

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2024	25	1	4.17%
Dec 31, 2023	24	3	14.29%
Dec 31, 2022	21	1	5.00%
Dec 31, 2021	20	8	66.67%
Dec 31, 2020	12	-4	-25.00%
Dec 31, 2019	Pro	Pro	Pro

Related Stocks

Company Name	Employees
UnitedHealth Group	400,000
Johnson & Johnson	138,100
Thermo Fisher Scientific	125,000
Abbott Laboratories	114,000
AstraZeneca	92,900
Novo Nordisk	77,349
Novartis AG	75,883
Merck & Co.	75,000

Employee Rankings

LGVN News

10 hours ago - Longeveron Inc. (LGVN) Q2 2025 Earnings Call Transcript - Seeking Alpha
17 hours ago - Longeveron® Announces Second Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
2 days ago - Longeveron Announces Closing Of Up To $17.5 Million Public Offering - GlobeNewsWire
5 days ago - Longeveron Announces Up To $17.5 Million Public Offering - GlobeNewsWire
9 days ago - Longeveron® to Report Second Quarter 2025 Financial Results and Host Conference Call on August 13, 2025 - GlobeNewsWire
24 days ago - Longeveron® Announces Licensing of New Cardiac Selective Induced Pluripotent Stem Cell Technology for Cardiovascular Disease - GlobeNewsWire
5 weeks ago - Longeveron® Announces U.S. FDA Approval of IND Application for a Phase 2 Pivotal Registration Study Evaluating Laromestrocel as a Treatment of Pediatric Dilated Cardiomyopathy (DCM) - GlobeNewsWire
7 weeks ago - Longeveron® Appoints Than Powell as Chief Business Officer - GlobeNewsWire